Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
Register now or login to post to this thread.

Fenner - Not Sexy But Profitable (FENR)     

queen1 - 22 Oct 2004 13:52

Dull business but cracking chart, great dividend and ad hoc takeover rumours. I'm happy to settle for that kind of dull!

skinny - 14 Jan 2015 12:31 - 267 of 312

Looks like I should have stayed in - did you buy Harry?

Credit Suisse Neutral 208.50 280.00 220.00 Reiterates

Canaccord Genuity Hold 208.50 400.00 250.00 Downgrades

Investec Hold 208.50 200.00 190.00 Reiterates

Panmure Gordon Sell 208.50 - 200.00 Reiterates

Numis Hold 208.50 - 220.00 Reiterates

Liberum Capital Hold 208.50 - - Reiterates

N+1 Singer Hold 208.50 201.00 201.00 Retains

finnCap Under Review 208.50 - - Under Review

HARRYCAT - 14 Jan 2015 12:53 - 268 of 312

I haven't. I still think this sector is out of favour, particularly as their customers are mostly within the mining industry, which is on it's knees atm. Sub 200p is likely again, imo.

skinny - 02 Feb 2015 07:08 - 269 of 312

Acquisition of Charter Medical Limited ("Charter")

Fenner is pleased to announce that its wholly owned subsidiary Fenner Drives, Inc. has acquired 100% of the share capital of Charter from its parent company Lydall, Inc. a publicly traded company (NYSE: LDL) headquartered in Connecticut. Charter will be integrated into Solesis Medical Technologies ("Solesis"), part of Fenner's AEP division.

The consideration of US$29.9m was satisfied in cash at completion and the transaction is expected to be earnings enhancing immediately upon acquisition.

Charter manufactures specialty single-use assemblies and Class I and Class II medical devices for the collection, processing, storage and filtration of biological and bioprocessing fluids. Charter also produces bio-containers and fluid management sets that serve a range of life science applications including biopharmaceutical manufacturing, cell therapy and cryogenic storage. Charter is a single site company based in Winston-Salem, North Carolina.

As at 31 December 2014, unaudited gross assets acquired were US$6.9m with underlying EBITDA (1) of US$3.3m for the 12 months to 31 December 2014 on sales of US$19.6m.

The entire workforce of Charter have become employees of Fenner upon completion and will continue to be led by General Manager, Mr. Gael Peron.

skinny - 04 Feb 2015 11:41 - 270 of 312

Looking better Harry?

Chart.aspx?Provider=EODIntra&Code=FENR&S

HARRYCAT - 04 Feb 2015 11:46 - 271 of 312

Not for me yet, I'm afraid.

skinny - 04 Feb 2015 16:12 - 272 of 312

Gap closed for now +7.1%.

skinny - 12 Mar 2015 07:06 - 273 of 312

Pre-Close Trading Statement

HARRYCAT - 22 Apr 2015 08:05 - 274 of 312

StockMarketWire.com
Fenner - a world leader in reinforced polymer technology - posts underlying operating profits of £28.7m for the six months to the end of February, down from £36.6m last time.

Revenues fell to £347.6m from £359.8m and underlying pre-tax profits dropped to £21.8m from £29.6m.

The group posts a pre-tax loss of £5.1m against a profit of £17.6m in 2014.

The interim dividend is maintained at 4.0p per share.

Chief executive Nicholas Hobson said: "The Group's results for the period reflect a good performance by the AEP division and a reduced result from the ECS division which faced challenging market conditions.

"AEP's industrial, medical and other non-oil speciality polymer businesses, which account for some 70 per cent of AEP's revenue, are expected to continue to perform well. The financial results for the second half of the year will also benefit from the acquisition of Charter Medical.

"The remainder of AEP is seeing an impact from lower levels of activity in the oil & gas industry as a result of sharply reduced oil and gas prices. Order intake started to decline in February; the timing and extent of the decline are within the range of our planning assumptions.

"ECS expects to see a continuation of the difficult trading conditions across all of its regions.

"In response to the trading conditions being faced, cash overheads across the Group have been reduced. The Group will continue to closely manage all aspects of its costs and cash flow.

"Taking into account the management actions we are taking in response to the trading conditions, the board's expectations for the outcome for the year remain substantially unchanged overall."

HARRYCAT - 22 Jul 2015 08:23 - 275 of 312

StockMarketWire.com
Fenner has warned that full year earnings, after recognising a lower tax rate, will be slightly below previous management expectations.

It says leading indicators in the mining and energy industries are not yet showing any signs of recovery and the group anticipates the recent challenging market conditions will continue.

It adds: "Nevertheless, we remain encouraged by the focussed way in which the ECS and oil and gas businesses are responding to cost management initiatives.

"We expect the strong performance by the industrial, medical and other non-oil businesses within AEP to continue for the remainder of the year and we anticipate that, for AEP as a whole, the outcome for the year will be in line with previous management expectations.

"However the recent developments in ECS's businesses will result in full year Group earnings, after recognising a lower tax rate, being slightly below previous management expectations.

"Cash exceptional costs in the current financial year arising from our programme to restructure and refocus our business are expected to remain in line with previous guidance at below £10m."

HARRYCAT - 22 Jul 2015 11:38 - 276 of 312

Jefferies International reiterates buy on Fenner, target cut from 235p to 220p.

skinny - 22 Jul 2015 11:47 - 277 of 312

Time to dust off the slide rule here?

CC - 22 Jul 2015 11:56 - 278 of 312

220 would be nice.

I have a very small quantity I bought at 195 and it hasn't been my best trade.

HARRYCAT - 22 Jul 2015 11:56 - 279 of 312

Yes, I have been tempted, but looking at the 10 year chart and bearing in mind that summer trading is usually very thin, I think there might be a bit more downside. However, on my watchlist.

HARRYCAT - 08 Sep 2015 08:44 - 280 of 312

StockMarketWire.com
Fenner expects group revenue and underlying profit for the year ended 31 August to be in line with forecasts at the time of the trading update on 22 July.

Net debt at 31 August was approximately £140 million, principally reflecting a better than anticipated outcome in respect of working capital.

The group expects to release its results for the full year on 11 November 2015.

skinny - 08 Sep 2015 13:57 - 281 of 312

Investec Sell 170.50 155.00 140.00 Reiterates

Liberum Capital Hold 170.50 - 200.00 Reiterates

finnCap Hold 170.50 175.00 175.00 Reiterates

CC - 08 Sep 2015 21:10 - 282 of 312

Big volume day today which may suggest the worst is over.

Chris Carson - 11 Nov 2015 07:41 - 284 of 312

Annual revenues fall 9% at Fenner

StockMarketWire.com

Fenner, a leader in reinforced polymer technology, has announced that Group revenue decreased by 9% to £666.7m in the year to August 31 2015 (2014: £729.4m).

Underlying operating profit decreased by 29% to £56.4m (2014: £79.5m).

The company says that throughout the year, there was stringent management of the cost base and several cost restructuring initiatives were completed.

Exceptional items amounted to a charge of £34.4m (2014: £19.7m). This comprised impairment costs relating to goodwill and intangible assets acquired of £24.5m and restructuring costs of £9.9m.

Overall this led to a loss before tax of £5.3m, compared to a profit of £29.2m in the previous year. Nicholas Hobson, chief executive officer, commented: "In the financial year to 31 August 2015, the Group has faced difficult trading conditions in some of its key markets. We have responded by rigorous control of costs and the close management of cash and working capital, whilst still maintaining our ability to resume growth when market conditions allow.

"Trading in the majority of the Group remains in line with management expectations. However, in the light of the recent further deterioration in the US coal industry, the Board envisages that the Group is likely to achieve an outcome for the current financial year which is moderately below its previous expectations."



HARRYCAT - 11 Nov 2015 12:02 - 285 of 312

Investec comment:
"Fenner has faced deteriorating markets for the last two years and the momentum is still downwards. The FY15 results were close enough to much-reduced expectations, but the outlook still requires a ‘moderate’ downward adjustment to guidance. We expect that FY16 consensus will be reduced by c.10% and we still see risk to the dividend (maintained for now and yielding almost 8%). On the expectation of lower estimates and given a PE-based valuation (currently under review), we reiterate our Sell recommendation.
Trading. Cost control in both operations and selective investment in AEP were the main themes of FY15, with market conditions providing very little cheer. Revenue declined by 9% (14% in ECS) and operating profits were down by 29%, in spite of management’s best efforts. The result for the year was close enough to our expectations, although these have been reduced 15 times in the last two years. However, conditions continue to deteriorate in the US coal industry and Fenner is guiding lower for FY16 as a result. Its ‘moderate’ change is unquantified, but we expect c.10%, and restructuring initiatives are to be announced soon.
Outlook. Fenner has taken a further £24.5m impairment charge (the same as in the prior year), which will have been based on expected future cash flows. In spite of the anticipated lower capex outflows (following completion of projects in AEP), we do not believe that earnings or cash flow will fully justify the current level of dividend distribution and we therefore maintain lower dividend estimates, notwithstanding the decision to pay 12.00p in respect of FY15.
Stance. Until we see end-market stability, it will be difficult to be confident in estimates for Fenner, and therefore to believe a valuation of the shares based on earnings. Clearly, we have not yet reached that point, so we maintain a Sell recommendation, with our detailed estimates and target price placed under review."

CC - 11 Nov 2015 20:24 - 286 of 312

Dividend yield of 8.5% with two thirds of it announced in today's RNS so secure
Register now or login to post to this thread.